Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-041310
Filing Date
2019-07-03
Accepted
2019-07-03 21:18:36
Documents
2
Period of Report
2019-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3899
2 POA DOCUMENT poa.txt EX-24.4_864267 3382
  Complete submission text file 0001209191-19-041310.txt   8658
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 5105213390
BIOTIME INC (Issuer) CIK: 0000876343 (see all company filings)

EIN.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 701 EDGEWATER DRIVE SUITE 360 WAKEFIELD MA 01880
Business Address
FARRELL STEPHEN C (Reporting) CIK: 0001188757 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12830 | Film No.: 19943075